sumithra Mohan

Dr. sumithra Mohan


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2023 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
RBRukaiah Fatma Begum
Rukaiah Fatma Begum
SMsumithra Mohan
sumithra Mohan

27 August 2024 in Cureus
Verified
Journal Article
Open access
PDF file
ARAkshaya R
Akshaya R
SMsumithra Mohan
sumithra Mohan
CVChitra Vellapandian
Chitra Vellapandian
A recessive X-linked illness called Duchenne muscular dystrophy (DMD) is characterized by increasing muscle weakening and degradation. It primarily affects boys and is one of the most prevalent and severe forms of muscular dystrophy. Mutations in the DMD gene, which codes for the essential protein dystrophin, which aids in maintaining the stability of muscle cell membranes during contraction, are the cause of the illness. Dystrophin deficiency or malfunction damages muscle cells, resulting in persistent inflammation and progressive loss of muscular mass. The pathophysiology and genetic foundation of DMD are thoroughly examined in this review paper, focusing on the function of the NF-κB signaling system in the disease’s progression. An important immune response regulator, NF-κB, is aberrantly activated in DMD, which exacerbates the inflammatory milieu in dystrophic muscles. Muscle injury and fibrosis are exacerbated and muscle regeneration is hampered by the pro-inflammatory cytokines and chemokines that are produced when NF-κB is persistently activated in muscle cells. The paper also examines our existing knowledge of treatment approaches meant to inhibit the progression of disease by modifying NF-κB signaling. These include new molecular techniques, gene treatments, and pharmacological inhibitors that are intended to lessen inflammation and improve muscle healing. Furthermore covered in the analysis is the significance of supportive care for DMD patients, including physical therapy and corticosteroid treatment, in symptom management and quality of life enhancement. The article seeks to provide a thorough understanding of the mechanisms causing DMD, possible therapeutic targets, and developing treatment options by combining recent research findings. This will provide clinicians and researchers involved in DMD care and research with invaluable insights.

19 November 2024 in Future Science OA
Verified
Journal Article
Open access
RBRukaiah Fatma Begum
Rukaiah Fatma Begum
CVChitra Vellapandian
Chitra Vellapandian
SMsumithra Mohan
sumithra Mohan
Polycystic Ovarian Syndrome (PCOS) is a reproductive disorder that significantly impacts women's quality of life (QOL). Its unclear etiology, whether genetic or environmental, and the treatments associated with it have been widely studied globally. This study assessed the QOL of 108 women with PCOS, examining both physical and mental symptoms. Participants completed the Short Form-12 (SF-12) questionnaire through a web-based survey to evaluate their QOL scores. Common symptoms included menstrual irregularity (73.14%), hirsutism (65.7%), acne (62.03%), and obesity (22.22%). Complications such as diabetes mellitus (12.9%), hypertension (2.78%), infertility (1.85%), miscarriages (31.4%), hyperandrogenism (68.51%), and insulin resistance (28.7%) were reported. Patients with infertility had the lowest physical scores (PCS), while those working night shifts had the lowest mental scores (MCS). PCOS significantly affects QOL, with infertility contributing to the lowest physical scores and night shift work correlating with the lowest mental scores. These findings emphasize the need for integrated psychological and physical care, particularly for young working women with PCOS.

1 October 2024 in Cureus
Verified
Journal Article
Open access
PDF file
RPRajabikramaditya Panda
Rajabikramaditya Panda
SMsumithra Mohan
sumithra Mohan
CVChitra Vellapandian
Chitra Vellapandian
Combining epigenetic alterations with cancer immunotherapy offers a promising approach to improve therapeutic outcomes by targeting the complex biology of tumors. Epigenetic mechanisms such as DNA methylation, histone modifications, and non-coding RNAs (ncRNAs) play a dual role in maintaining immune homeostasis and promoting cancer progression. Changes like hypomethylation in tumor cells can contribute to immune evasion and treatment resistance. Advances in epigenetic tools, particularly clustered regularly interspaced short palindromic repeat (CRISPR) and their associated protein (Cas9)-based epigenetic editing, allow for precise gene expression control, opening new avenues for research and therapy. The improved accuracy of CRISPR/dCas9 systems, when paired with appropriate delivery methods such as viral vectors or nanoparticles, has facilitated innovative combination therapies involving immune checkpoint inhibitors and epigenetic drugs. These combinations enhance the immune system's ability to recognize and destroy cancer cells. Despite these advancements, challenges like off-target effects, delivery issues, and resistance remain. Current research is focused on identifying new therapeutic targets, improving delivery systems, and using real-time feedback to refine treatment. Overall, combining immunotherapy with epigenetic modifications holds significant potential for personalized cancer treatment, paving the way for more effective and individualized therapeutic strategies that target both the immune system and the tumor microenvironment. Further development in this area is expected to revolutionize cancer therapy and improve patient outcomes.

20 December 2022 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
SVSharmila Devi Veeraswamy
Sharmila Devi Veeraswamy
IRIlavarasan Raju
Ilavarasan Raju
SMsumithra Mohan
sumithra Mohan
In the current scenario, there is a thirst for research against emerging microorganisms, and it becomes challenging to introduce new drugs against organism virulence are pretty interesting. Herbal medicines are now gaining popularity as a treatment option for various diseases worldwide. The present study analyzes the antifungal effect of a polyherbal formulation through in vitro well diffusion method using fungal strains such as Candida albicans, Aspergillus niger, Aspergillus fumigatus, Cryptococcus neoformans, and Sporothrix schenckii. Molecular docking is done using the Auto dock vina tool to predict the mechanism of action of the phytomolecules present in the polyherbal formulation. The molecular interactions are visualized using molecular modelling (PyMOL) software. The antifungal effect was observed in a concentration-dependent manner with a significant zone of inhibition. Also, phytomolecules in polyherbal formulation showed potential inhibition on CYP450 Lanosterol 14 α-demethylase 1, 3 β-Glucan synthase, and Thymidylate synthase from docking analysis.

5 May 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
KKKoteeswaran Kannan
Koteeswaran Kannan
SMsumithra Mohan
sumithra Mohan